Vyome Holdings, Inc. (HIND)
3.68
-0.20
(-5.08%)
USD |
NASDAQ |
Dec 19, 16:00
3.62
-0.06
(-1.63%)
After-Hours: 20:00
Vyome Holdings EPS Diluted (Quarterly): -3.057 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.595M |
| Revenue (Quarterly) | 0.0346M |
| Total Expenses (Quarterly) | 8.468M |
| Enterprise Value | -3.564M |
| Gross Profit Margin (Quarterly) | 43.93% |
| Profit Margin (Quarterly) | -24.84K% |
| Earnings Yield | -4.82K% |
| Normalized Earnings Yield | -5224.85 |